About
Scott Byrd is an Entrepreneur-in-Residence at Frazier Life Sciences, which he joined in May 2020, and has more than 25 years of pharmaceutical industry experience. He was previously CEO of Outpost Medicine and President and COO of Acacia Pharma, Inc., and earlier served as SVP and Chief Commercial Officer of Cadence Pharmaceuticals, where he led the launch of OFIRMEV. He began his career in a range of roles at Eli Lilly and holds a B.S. in mechanical engineering from Bradley University and an M.B.A. from Harvard Business School.
Invests in
Biotech
Experience
- Sudo BiosciencesChief Executive Officercurrent2021 — present
- Frazier Life SciencesEntrepreneur In Residencecurrent2020 — present
- AlgoTxBoard Member2021 — 2025Paris, France
- ACACIA PHARMA GROUP LIMITEDChairman Of The Board2020 — 2022Greater Cambridge Area
- Outpost MedicinePresident & CEO2017 — 2021Greater Indianapolis
- Acacia Pharma Inc.COO, President - Acacia Pharma Inc.2015 — 2017Greater Indianapolis
- SAB Strategic Advisors LLCPresident, CEO2014 — 2015
- Cadence PharmaceuticalsSVP, Chief Commercial Officer2009 — 2014
- Eli Lilly and CompanyUS and Global Brand Leader - Cardiovascular and Critical Care1992 — 2009
Skills & more
Pharmaceutical Sales61Marketing Strategy8Hospital Sales30Infectious Diseases11FinanceCritical Care1Product Launch26Commercialization19Oncology14Global Marketing9Medical Devices11Biotechnology33
+12 more
Cross-functional Team LeadershipSales EffectivenessMarket AccessDiabetesCardiologyClinical DevelopmentCompetitive IntelligenceBrand ManagementStrategyLeadershipPharmaceutical IndustryMarket ResearchFrom Scott's professional profile.
Investments
Board seats
Acacia Pharma Group plc
Per the firm's website.
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
Frequently asked questions
- Who is Scott Byrd?
- Scott Byrd is an Entrepreneur-in-Residence at Frazier Life Sciences, which he joined in May 2020, and has more than 25 years of pharmaceutical industry experience. He was previously CEO of Outpost Medicine and President and COO of Acacia Pharma, Inc., and earlier served as SVP and Chief Commercial Officer of Cadence Pharmaceuticals, where he led the launch of OFIRMEV. He began his career in a range of roles at Eli Lilly and holds a B.S. in mechanical engineering from Bradley University and an M.B.A. from Harvard Business School.
- Where does Scott Byrd work?
- Scott Byrd is Entrepreneur-in-Residence at Frazier Life Sciences.
- What does Scott Byrd invest in?
- Scott Byrd invests in Biotech.
- What boards does Scott Byrd sit on?
- Scott Byrd holds tracked board seats at Acacia Pharma Group plc.
- Where did Scott Byrd go to school?
- Scott Byrd studied at Harvard Business School (MBA); Bradley University (BSME, Mechanical Engineering).
Founder mafias
Harvard Business School mafia323
Also came through, then founded or led a company.
Mike Maples JrMBAFounded Pattern BreakersHristo BorisovOPM Class 64Founded PayhawkNoubar AfeyanVisiting LecturerFounded ProFound Therapeutics +12Wade MyersMBAFounded RealManage +5Harry GrunerFounded Hilos +2Ellen RubinMBAFounded ClearSky Data +2
+ 316 more
Frazier Life Sciences mafia14
Also came through, then founded or led a company.
Christian SchadeSenior AdvisorFounded Halda Therapeutics +2Maria FardisVenture PartnerFounded Airnexis Therapeutics Inc +1Aditya KohliPartnerFounded Phathom PharmaceuticalsJames LiVenture PartnerFounded JW TherapeuticsTao FuVenture PartnerFounded Attovia Therapeutics
+ 8 more
Sudo Bio mafia3
Also came through, then founded or led a company.
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesVictoria TreygerGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystAdrianna MaInvestor at Index Ventures
+ 1,994 more
Also attended Bradley University9
Brent HillManaging Partner at Origin VenturesBrian LindstromPartner at HealthX VenturesAljoscha KaplanPartner and Co-Founder at German Media PoolNoël AdamsVice President, Academic Collaborations and Simulation Operations at OSF VenturesMark GrosshansPrincipal, Financial Performance at FrontenacBob DiMeoAdvisor — Chairman & Co-founder of Fiducient Advisors at Distributed Ventures
+ 3 more
Shared employers
Also worked at Sudo Biosciences7
Christopher GagliardiPrincipal at Sanofi VenturesGordon McMurrayEntrepreneur-in-Residence at Frazier Life SciencesIan W. MillsEntrepreneur-in-Residence at Frazier Life SciencesMiles GersonPartner at Dementia Discovery FundRomain TouyéInvestor Relations Analyst at MBO+Jonathan BehrPartner at SV Health Investors
+ 1 more
Also worked at Acacia Pharma Inc.2
Also worked at Eli Lilly and Company97
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi Invest
+ 91 more